Interleukin-1 receptor antagonist (IL-1ra) protects against tissue injury in an animal model of hemorrhagic colitis.

被引：0
|
作者：
Bloom, PD
Russell, R
Blake, D
Boedeker, E
机构：
[1] VAMC, RES SERV, BALTIMORE, MD USA
[2] UNIV MARYLAND, GI DIV, BALTIMORE, MD 21201 USA
[3] UNIV MARYLAND, CTR VACCINE DEV, BALTIMORE, MD 21201 USA
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A938 / A938
页数：1
相关论文
共 50 条
  • [31] Effects of leflunomide on interleukin-1 receptor antagonist (IL-1Ra) synthesis in chondrocytes and synovial fibroblasts
    G Palmer
    D Burger
    F Mezin
    C Gabay
    J-M Dayer
    P-A Guerne
    Arthritis Res Ther, 5 (Suppl 1):
  • [32] INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) FOLLOWING SURGERY IS ASSOCIATED WITH MAJOR TRAUMA
    NUALLAIN, EMO
    PURI, P
    MEALY, K
    REEN, DJ
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 76 (01): : 96 - 101
  • [33] SUPPRESSION OF ESTABLISHED RAT CRESCENTIC GLOMERULONEPHRITIS (GN) BY THE INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA)
    LAN, HY
    NIKOLICPATERSON, DJ
    MU, W
    ATKINS, RC
    KIDNEY INTERNATIONAL, 1994, 46 (03) : 926 - 926
  • [34] The Experimental Treatment of Corneal Graft Rejection with the Interleukin-1 Receptor Antagonist (IL-1ra) Gene
    Yuan, Jin
    Liu, Yi
    Huang, Weilan
    Zhou, Shiyou
    Ling, Shiqi
    Chen, Jiaqi
    PLOS ONE, 2013, 8 (05):
  • [35] Interleukin-1 receptor antagonist (IL-1Ra) targets the proliferative component in early stage myeloma
    Lust, JA
    Lacy, MQ
    Dispenzieri, A
    Gertz, MA
    Zeldenrust, SR
    Greipp, PR
    Witzig, TE
    Hoering, A
    Moon-Tasson, LL
    Timm, MM
    Rajkumar, SV
    Donovan, KA
    BLOOD, 2004, 104 (11) : 663A - 663A
  • [36] Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns
    Endo, S
    Inada, K
    Yamada, Y
    Kasai, T
    Takakuwa, T
    Nakae, H
    Kamei, Y
    Shimamura, T
    Suzuki, T
    Taniguchi, S
    Yoshida, M
    JOURNAL OF MEDICINE, 1996, 27 (1-2) : 57 - 71
  • [37] RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) - EFFECTIVE THERAPY AGAINST GRAM-NEGATIVE SEPSIS IN RATS
    ALEXANDER, HR
    DOHERTY, GM
    VENZON, DJ
    MERINO, MJ
    FRAKER, DL
    NORTON, JA
    SURGERY, 1992, 112 (02) : 188 - 194
  • [38] Serum levels of interleukin 1 receptor antagonist (IL-1RA) and soluble tumor necrosis factor α-receptor (sTNFα-R) in severe attacks of ulcerative colitis.
    Péré-Vergé, D
    Bienvenu, J
    Flourié, B
    Descos, L
    GASTROENTEROLOGY, 1998, 114 (04) : A1060 - A1060
  • [39] Imbalance production between interleukin-1β (IL-1β) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma
    Mao, XQ
    Kawai, M
    Yamashita, T
    Enomoto, T
    Dake, Y
    Sasaki, S
    Kataoka, Y
    Fukuzumi, T
    Endo, K
    Sano, H
    Aoki, T
    Kurimoto, F
    Adra, CN
    Shirakawa, T
    Hopkin, JM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (02) : 607 - 612
  • [40] Anti-inflammatory effects of IL-1 receptor antagonist (IL-1ra) gene therapy in experimental rabbit colitis.
    Alabanza, PL
    Woraratanadharm, J
    Kozaiwa, K
    Huybrechts, MM
    Fox, LM
    Nast, CC
    Pizarro, TT
    GASTROENTEROLOGY, 1999, 116 (04) : A660 - A660
12345